Shioda T

No ORCID on file · 3 papers in corpus · active 2012-2015
2015
Progesterone receptor membrane component 1 deficiency attenuates growth while promoting chemosensitivity of human endometrial xenograft tumors.
Cancer letters ·doi:10.1016/j.canlet.2014.09.036

Endometrial cancer is the leading gynecologic cancer in women in the United States with 52,630 women predicted to be diagnosed with the disease in 2014. The objective of this study was to determine if progesterone (P4) receptor membrane com…

2013
Regulatory decisions on endocrine disrupting chemicals should be based on the principles of endocrinology.
Reproductive toxicology (Elmsford, N.Y.) ·doi:10.1016/j.reprotox.2013.02.002

For years, scientists from various disciplines have studied the effects of endocrine disrupting chemicals (EDCs) on the health and wellbeing of humans and wildlife. Some studies have specifically focused on the effects of low doses, i.e. th…

2012
Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses.
Endocrine reviews ·doi:10.1210/er.2011-1050

For decades, studies of endocrine-disrupting chemicals (EDCs) have challenged traditional concepts in toxicology, in particular the dogma of "the dose makes the poison," because EDCs can have effects at low doses that are not predicted by e…